Effects of some vasopressor drugs upon uterine contractility in pregnant women.
D000653:Amniotic Fluid; D000757:Anencephaly; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D005313:Fetal Death; D005318:Fetal Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007231:Infant, Newborn; D007743:Labor, Obstetric / Q000187:drug effects; D008616:Mephentermine / Q000494:pharmacology; D008729:Methoxamine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D009655:Octopamine / Q000494:pharmacology; D011247:Pregnancy / Q000187:drug effects*; D011312:Pressure; D013565:Sympatholytics / Q000378:metabolism; D014599:Uterus / Q000187:drug effects*; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*
D013565:Sympatholytics; D014662:Vasoconstrictor Agents; D009655:Octopamine; D008729:Methoxamine; D008616:Mephentermine; D009638:Norepinephrine